143 related articles for article (PubMed ID: 31878933)
41. Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK activation in HBV transgenic mice.
Dai S; Chen X; Yu Y; Zang G; Tang Z
Mol Med Rep; 2018 Nov; 18(5):4691-4699. PubMed ID: 30221736
[TBL] [Abstract][Full Text] [Related]
42. Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation.
Zarei S; Leuba F; Arrighi JF; Hauser C; Piguet V
J Allergy Clin Immunol; 2002 Jun; 109(6):988-94. PubMed ID: 12063529
[TBL] [Abstract][Full Text] [Related]
43. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
[TBL] [Abstract][Full Text] [Related]
44. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin beta.
He LZ; Ramakrishna V; Connolly JE; Wang XT; Smith PA; Jones CL; Valkova-Valchanova M; Arunakumari A; Treml JF; Goldstein J; Wallace PK; Keler T; Endres MJ
Clin Cancer Res; 2004 Mar; 10(6):1920-7. PubMed ID: 15041707
[TBL] [Abstract][Full Text] [Related]
45. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
46. rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer.
Yu Y; Pilgrim P; Zhou W; Gagliano N; Frezza EE; Jenkins M; Weidanz JA; Lustgarten J; Cannon M; Bumm K; Cobos E; Kast WM; Chiriva-Internati M
Viral Immunol; 2008 Dec; 21(4):435-42. PubMed ID: 19115932
[TBL] [Abstract][Full Text] [Related]
47. Induction of T cell responses against autologous ovarian tumors with whole tumor cell lysate-pulsed dendritic cells.
Zhao X; Wei YQ; Peng ZL
Immunol Invest; 2001 Feb; 30(1):33-45. PubMed ID: 11419910
[TBL] [Abstract][Full Text] [Related]
48. Exposure to nicotine adversely affects the dendritic cell system and compromises host response to vaccination.
Nouri-Shirazi M; Guinet E
J Immunol; 2012 Mar; 188(5):2359-70. PubMed ID: 22279108
[TBL] [Abstract][Full Text] [Related]
49. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
50. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
Lim SN; Kuhn S; Hyde E; Ronchese F
J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
[TBL] [Abstract][Full Text] [Related]
51. Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2).
Sato M; Takayama T; Tanaka H; Konishi J; Suzuki T; Kaiga T; Tahara H
Cancer Sci; 2003 Dec; 94(12):1091-8. PubMed ID: 14662025
[TBL] [Abstract][Full Text] [Related]
52. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
53. Gadd45alpha regulates p38-dependent dendritic cell cytokine production and Th1 differentiation.
Jirmanova L; Jankovic D; Fornace AJ; Ashwell JD
J Immunol; 2007 Apr; 178(7):4153-8. PubMed ID: 17371971
[TBL] [Abstract][Full Text] [Related]
54. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.
Yang W; Feng J; Chang X; Fu T; Ye X; Zhang H; Li X; Wen H; Feng L; Tong C; Cui H
Gynecol Oncol; 2007 Apr; 105(1):238-43. PubMed ID: 17383546
[TBL] [Abstract][Full Text] [Related]
55. MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor.
Broder H; Anderson A; Kremen TJ; Odesa SK; Liau LM
J Neurooncol; 2003; 64(1-2):21-30. PubMed ID: 12952283
[TBL] [Abstract][Full Text] [Related]
56. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.
Oh ST; Kim CH; Park MY; Won EH; Sohn HJ; Cho HI; Kang WK; Hong YK; Kim TG
Vaccine; 2006 Apr; 24(15):2860-8. PubMed ID: 16443309
[TBL] [Abstract][Full Text] [Related]
57. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
[TBL] [Abstract][Full Text] [Related]
58. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
59. Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus.
Mahadevan M; Liu Y; You C; Luo R; You H; Mehta JL; Hermonat PL
Cancer Immunol Immunother; 2007 Oct; 56(10):1615-24. PubMed ID: 17356843
[TBL] [Abstract][Full Text] [Related]
60. The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.
Martin K; Müller P; Schreiner J; Prince SS; Lardinois D; Heinzelmann-Schwarz VA; Thommen DS; Zippelius A
Cancer Immunol Immunother; 2014 Sep; 63(9):925-38. PubMed ID: 24906866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
